CysLT1 antagonist, 1,4-dihydroxy quininib, alters the secretion of inflammatory mediators from primary uveal melanoma explants and reduces ATP5B expression in a metastatic xenograft model
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要